There was no evidence of significant interaction between the effects of SGLT2 inhibition and RAAS inhibition status on the composite outcome of cardiovascular death or HF hospitalization (p‐value for meta‐regression = .12). Here, SLC5A2 is linked to hydrops fetalis.